mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.1 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.066 |
0.1 |